참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Sodium Carbonate | HCID 10340 | — |
| 반응물 | Tri-o-tolylphosphine | HCID 80271 | — |
| 반응물 | B-2,1,3-Benzoxadiazol-4-ylboronic acid | HCID 21186805 | — |
| 반응물 | 4-(8-Bromo-1,7-naphthyridin-6-yl)benzoic acid | HCID 23284646 | — |
| 촉매 | 1,5-Diphenylpenta-1,4-dien-3-one;palladium | HCID 154270 | — |
| 용매 | Dimethylformamide | HCID 6228 | — |
| 생성물 | 6-(4-Carboxyphenyl)-8-(4-benzo[c]furazanyl)-1,7-naphthyridine | HCID 23284638 | 60.7% |
반응 단계
To a solution of 6-(4-carboxyphenyl)-8-bromo-1,7-naphthyridine (100 mg, 0.304 mmol) in DMF (2.5 ml) is added 4-benzo[c]furazanyl boronic acid (60 mg, 0.36 mmol), bis(dibenzylidenacetone) palladium (7 mg, 0.0122 mmol), tri-o-tolylphosphine (7.4 mg, 0.024 mmol) and aqueous Na2CO3 (0.9 ml, 2N). The reaction mixture is stirred at 80° for 2 h. The hot solution is filtred through cellit and the solution evaporated to dryness. The residue is stirred in ethyl acetate (20 ml), the suspension is filtered and the organic solvent is removed. The residue is dissolved in hot DMF (7 ml) and the crude product is precipitated by carefully adding aqueous HCl (2N, 1 ml). The crude product in recrystallized from hot DMF to yield the title compound (68 mg). MH+369; Melting point >300° C. M+H=369. Retention time HPLC=10.40 min (column: LiChroCart 125-4, Supersphere 60 RP-select B, 40°; eluent: acetonitril-water (0.1% TFA)=45:55; 1 ml/min; detection at 254 nm).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US06136821 |
|---|
| 출처 데이터셋 | uspto-grants-2000_10 |
|---|
| ORD ID | ord-3e909dee7bf24e4f821be6c1c311f31c |
|---|
| 출처 메모 | uspto-grants-2000_10 |
|---|